112 related articles for article (PubMed ID: 38247332)
21. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells.
Zhang P; Lu X; Shi Z; Li X; Zhang Y; Zhao S; Liu H
Gene; 2019 Aug; 710():103-113. PubMed ID: 31158447
[TBL] [Abstract][Full Text] [Related]
22. The important role of the receptor for activated C kinase 1 (RACK1) in nasopharyngeal carcinoma progression.
Peng H; Gong PG; Li JB; Cai LM; Yang L; Liu YY; Yao KT; Li X
J Transl Med; 2016 May; 14(1):131. PubMed ID: 27170279
[TBL] [Abstract][Full Text] [Related]
23. Silencing of lncRNA MIR31HG promotes nasopharyngeal carcinoma cell proliferation and inhibits apoptosis through suppressing the PI3K/AKT signaling pathway.
Feng B; Chen K; Zhang W; Zheng Q; He Y
J Clin Lab Anal; 2022 Dec; 36(12):e24720. PubMed ID: 36347827
[TBL] [Abstract][Full Text] [Related]
24. PD-L1 Induces Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma Cells Through Activation of the PI3K/AKT Pathway.
Fei Z; Deng Z; Zhou L; Li K; Xia X; Xie R
Oncol Res; 2019 Jul; 27(7):801-807. PubMed ID: 30982497
[TBL] [Abstract][Full Text] [Related]
25. Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts.
Lin YT; Wang HC; Chuang HC; Hsu YC; Yang MY; Chien CY
J Mol Med (Berl); 2018 Dec; 96(12):1407-1418. PubMed ID: 30374682
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA‑122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma in vitro.
Yang Y; Li Q; Guo L
Mol Med Rep; 2018 Jun; 17(6):8244-8252. PubMed ID: 29693120
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-34a inhibits cell invasion and epithelial-mesenchymal transition via targeting AXL/PI3K/AKT/Snail signaling in nasopharyngeal carcinoma.
Jiang C; Cheng Z; Jiang T; Xu Y; Wang B
Genes Genomics; 2020 Aug; 42(8):971-978. PubMed ID: 32648233
[TBL] [Abstract][Full Text] [Related]
28. EGFR-PKM2 signaling promotes the metastatic potential of nasopharyngeal carcinoma through induction of FOSL1 and ANTXR2.
Chen S; Youhong T; Tan Y; He Y; Ban Y; Cai J; Li X; Xiong W; Zeng Z; Li G; Yi M; Liu W; Xiang B
Carcinogenesis; 2020 Jul; 41(6):723-733. PubMed ID: 31665243
[TBL] [Abstract][Full Text] [Related]
29. Circ_0000523 regulates miR-1184/COL1A1/PI3K/Akt pathway to promote nasopharyngeal carcinoma progression.
Huang P; Li M; Tang Q; Jiang K; Luo Y
Apoptosis; 2022 Oct; 27(9-10):751-761. PubMed ID: 35759163
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-142 promotes the development of nasopharyngeal carcinoma through targeting PTEN.
Li DP; Chai W; Liu YH; Xu TT; Huang H
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3806-3812. PubMed ID: 31115007
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-199a-3p suppresses the invasion and metastasis of nasopharyngeal carcinoma through SCD1/PTEN/AKT signaling pathway.
Hu W; Wang Y; Zhang Q; Luo Q; Huang N; Chen R; Tang X; Li X; Luo H
Cell Signal; 2023 Oct; 110():110833. PubMed ID: 37543098
[TBL] [Abstract][Full Text] [Related]
32. FLI1 regulates radiotherapy resistance in nasopharyngeal carcinoma through TIE1-mediated PI3K/AKT signaling pathway.
Chen E; Huang J; Chen M; Wu J; Ouyang P; Wang X; Shi D; Liu Z; Zhu W; Sun H; Yang S; Zhang B; Deng W; Qiu H; Xie F
J Transl Med; 2023 Feb; 21(1):134. PubMed ID: 36814284
[TBL] [Abstract][Full Text] [Related]
33. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
Hu W; Xiao L; Cao C; Hua S; Wu D
Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
[TBL] [Abstract][Full Text] [Related]
34. Saucerneol attenuates nasopharyngeal carcinoma cells proliferation and metastasis through selectively targeting Grp94.
Cheng Y; Wang Q; Zhang Z; Zhao C; Zhou H; Xu J; Gu Q
Phytomedicine; 2022 Jul; 101():154133. PubMed ID: 35504052
[TBL] [Abstract][Full Text] [Related]
35. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN.
Cai LM; Lyu XM; Luo WR; Cui XF; Ye YF; Yuan CC; Peng QX; Wu DH; Liu TF; Wang E; Marincola FM; Yao KT; Fang WY; Cai HB; Li X
Oncogene; 2015 Apr; 34(17):2156-66. PubMed ID: 25347742
[TBL] [Abstract][Full Text] [Related]
36. ARHGAP42 promotes cell migration and invasion involving PI3K/Akt signaling pathway in nasopharyngeal carcinoma.
Hu Q; Lin X; Ding L; Zeng Y; Pang D; Ouyang N; Xiang Y; Yao H
Cancer Med; 2018 Aug; 7(8):3862-3874. PubMed ID: 29936709
[TBL] [Abstract][Full Text] [Related]
37. SPEN induces miR-4652-3p to target HIPK2 in nasopharyngeal carcinoma.
Li Y; Lv Y; Cheng C; Huang Y; Yang L; He J; Tao X; Hu Y; Ma Y; Su Y; Wu L; Yu G; Jiang Q; Liu S; Liu X; Liu Z
Cell Death Dis; 2020 Jul; 11(7):509. PubMed ID: 32641685
[TBL] [Abstract][Full Text] [Related]
38. Annexin A1-suppressed autophagy promotes nasopharyngeal carcinoma cell invasion and metastasis by PI3K/AKT signaling activation.
Zhu JF; Huang W; Yi HM; Xiao T; Li JY; Feng J; Yi H; Lu SS; Li XH; Lu RH; He QY; Xiao ZQ
Cell Death Dis; 2018 Nov; 9(12):1154. PubMed ID: 30459351
[TBL] [Abstract][Full Text] [Related]
39. Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma.
Zhen Y; Liu Z; Yang H; Yu X; Wu Q; Hua S; Long X; Jiang Q; Song Y; Cheng C; Wang H; Zhao M; Fu Q; Lyu X; Chen Y; Fan Y; Liu Y; Li X; Fang W
Cell Death Dis; 2013 Oct; 4(10):e872. PubMed ID: 24157866
[TBL] [Abstract][Full Text] [Related]
40. LASP1 promotes nasopharyngeal carcinoma progression through negatively regulation of the tumor suppressor PTEN.
Gao Q; Tang L; Wu L; Li K; Wang H; Li W; Wu J; Li M; Wang S; Zhao L
Cell Death Dis; 2018 Mar; 9(3):393. PubMed ID: 29531214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]